Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma
Yamashiki, M.; Kosaka, Y.
Rinsho Byori. Japanese Journal of Clinical Pathology 37(2): 118-121
1989
ISSN/ISBN: 0047-1860 PMID: 2471846 Document Number: 346245
Document emailed within 1 workday
Related Documents
Sakon, M.; Monden, M.; Gotoh, M.; Kobayashi, K.; Kanai, T.; Umeshita, K.; Endoh, W.; Mori, T. 1991: The effects of vitamin K on the generation of des-gamma-carboxy prothrombin (PIVKA-II) in patients with hepatocellular carcinoma American Journal of Gastroenterology 86(3): 339-345Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154
Kawakita, T.; Shiraki, K.; Yamanaka, Y.; Yamaguchi, Y.; Saitou, Y.; Enokimura, N.; Yamamoto, N.; Okano, H.; Sugimoto, K.; Murata, K.; Yamakado, K.; Takeda, K.; Nakano, T. 2003: A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma International Journal of Oncology 23(4): 1115-1120
Tang, W.; Miki, K.; Kokudo, N.; Sugawara, Y.; Imamura, H.; Minagawa, M.; Yuan, L-Wen.; Ohnishi, S.; Makuuchi, M. 2003: Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma International Journal of Oncology 22(5): 969-975
Izuno, K.; Fujiyama, S.; Yamasaki, K.; Sato, M.; Sato, T. 1995: Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study Hepato-Gastroenterology 42(4): 387-393
Tsugawa, D.; Fukumoto, T.; Kido, M.; Takebe, A.; Tanaka, M.; Kuramitsu, K.; Matsumoto, I.; Ajiki, T.; Koyama, T.; Ku, Y. 2015: The Predictive Power of Serum α-Fetoprotein and Des-γ-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma Kobe journal of medical sciences 61(5): E124-E131
Hasegawa, Y.; Tomita, K.; Hashimoto, K.; Shigeoka, Y.; Watanabe, M.; Yamasaki, A.; Shimizu, E. 2005: Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation Anticancer Research 25(6c): 4569-4571
Yamano, M. 1990: Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 999-1002
Tanabe, Y.; Ohnishi, K.; Nomura, F.; Iida, S. 1988: Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma American Journal of Gastroenterology 83(12): 1386-1389
Fujiyama, S.; Morishita, T.; Sagara, K.; Sato, T.; Motohara, K.; Matsuda, I. 1986: Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma Hepato-Gastroenterology 33(5): 201-205
Okuda, H.; Nakanish, T.; Furukawa, M.; Yamagata, H.; Obata, H. 1991: Abnormal prothrombin (PIVKA-II) and hepatocellular carcinoma Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 12(2): 59-66
Akahane, Y. 2001: Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 474-477
Sawabu, N.; Toya, D.; Yoneshima, M.; Kidani, H.; Hattori, N. 1984: Novel gamma-GTP isoenzyme and hepatocellular carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 30(6 Suppl): 563-568
Brunello, F.; Marcarino, C.; Pasquero, P.; Gastaldi, P.; Gonella, S.; Martini, S.; Calcamuggi, G.; Emanuelli, G. 1993: The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma Italian Journal of Gastroenterology 25(1): 9-12
Tarao, K.; Ohkawa, S.; Tamai, S.; Shimizu, A. 1995: Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 740-745
Xu, K.; Meng, X.Y.; Wu, J.W.; Shen, B.; Shi, Y.C.; Wei, Q. 1992: Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study American Journal of Gastroenterology 87(8): 991-995
Kapp, P.; Bély, M.; Nemesánszky, E.; Szende, B. 2001: The role of perisinusoidal (Ito) cells in the course of hepatocellular carcinoma: light and electron microscopic data to the pathogenesis of hepatocellular carcinoma Orvosi Hetilap 142(49): 2741-2746
Zenali, M.J.; Tan, D.; Li, W.; Dhingra, S.; Brown, R.E. 2010: Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma Annals of Clinical and Laboratory Science 40(2): 126-134
Takeda, Y. 1970: Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system Journal of Laboratory and Clinical Medicine 75(3): 355-381
Gentsch, C.; Martius, C. 1981: Detection of gamma-carboxy glutamic acid residues in an extract of cock spermatozoa Experientia 37(12): 1261-1263